Hendriksen P H, Oey P L, Wieneke G H, Bravenboer B, Banga J D
Department of Clinical Neurophysiology, University Hospital, Utrecht, The Netherlands.
Diabetologia. 1992 Jul;35(7):690-5. doi: 10.1007/BF00400264.
Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetic patients share many clinical and biochemical characteristics. However, sural nerve biopsies from patients with advanced and chronic neuropathy show ultrastructural differences between these two groups. We investigated whether at a subclinical stage of the illness, when Type 1 and Type 2 diabetic patients are clinically uniform and the histopathological nerve alterations are not advanced, comparison between the two diabetes groups might show differences in nerve fibre involvement related to the different pathogeneses of the neuropathies. A total of 88 diabetic patients (52 Type 1 and 36 Type 2), with a subclinical form of polyneuropathy were selected. The clinical neurophysiological examination consisted of motor and sensory nerve conduction studies, Hoffmann (H)-reflex, single fibre electromyography and static as well as dynamic pupillometry. With regard to clinical neurophysiological abnormalities, the severity of the polyneuropathy appeared to be equal in both groups. Despite the absence of clinical symptoms the neurophysiological abnormalities were pronounced and it was impossible to differentiate Type 1 diabetic patients from Type 2 diabetic patients on a clinical neurophysiology basis when correcting for differences in age, height, and duration of illness. In the Type 1 diabetic group as well as in the Type 2 diabetic group the autonomic nerve fibres and nerves in the legs were more frequently affected than the thick myelinated nerves in the arms. These findings do not support the assumption that there is a difference in the manifestation of polyneuropathy between Type 1 and Type 2 diabetic patients.
1型(胰岛素依赖型)和2型(非胰岛素依赖型)糖尿病患者有许多共同的临床和生化特征。然而,对患有晚期和慢性神经病变患者的腓肠神经活检显示,这两组患者存在超微结构差异。我们研究了在疾病的亚临床阶段,即1型和2型糖尿病患者在临床上表现一致且组织病理学神经改变尚未进展时,比较这两组糖尿病患者是否会显示出与神经病变不同发病机制相关的神经纤维受累差异。总共选取了88例患有亚临床型多发性神经病变的糖尿病患者(52例1型和36例2型)。临床神经生理学检查包括运动和感觉神经传导研究、霍夫曼(H)反射、单纤维肌电图以及静态和动态瞳孔测量。关于临床神经生理学异常,两组多发性神经病变的严重程度似乎相同。尽管没有临床症状,但神经生理学异常很明显,在校正年龄、身高和病程差异后,基于临床神经生理学无法区分1型糖尿病患者和2型糖尿病患者。在1型糖尿病组和2型糖尿病组中,自主神经纤维和腿部神经比手臂上的粗有髓神经更常受到影响。这些发现不支持1型和2型糖尿病患者在多发性神经病变表现上存在差异的假设。